ALK and non-small cell lung carcinoma: Anaplastic lymphoma kinase (ALK) rearrangements, which are generally associated with pulmonary adenocarcinomas in female non-smokers, occur in approximately 5% of patients with non-small cell lung cancer (NSCLC).